Page last updated: 2024-08-25

methotrexate and Benign Cranial Nerve Neoplasms

methotrexate has been researched along with Benign Cranial Nerve Neoplasms in 2 studies

Research

Studies (2)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (50.00)	29.6817
2010's	1 (50.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Assanelli, A; Baldini, L; Caligaris-Cappio, F; Ferrari, A; Ferreri, AJ; Foppoli, M; Frezzato, M; Frungillo, N; Ilariucci, F; Licata, G; Mappa, S; Marturano, E; Proserpio, I; Reni, M; Sorarù, M; Stelitano, C; Vianello, F	1
Izumoto, S; Kinoshita, M; Maruno, M; Moriuchi, S; Nonaka, M; Oshino, S; Yoshimine, T	1

Reviews

1 review(s) available for methotrexate and Benign Cranial Nerve Neoplasms

Article	Year
Primary malignant lymphoma of the trigeminal region treated with rapid infusion of high-dose MTX and radiation: case report and review of the literature. Surgical neurology, 2003, Volume: 60, Issue:4 Topics: Antimetabolites, Antineoplastic; Chemotherapy, Adjuvant; Cranial Irradiation; Cranial Nerve Neoplasms; Drug Administration Schedule; Humans; Infusions, Intravenous; Lymphoma; Magnetic Resonance Imaging; Male; Methotrexate; Middle Aged; Radiotherapy, Adjuvant; Spine; Treatment Outcome; Trigeminal Nerve Diseases; Trigeminal Neuralgia	2003

Article

Year

Primary malignant lymphoma of the trigeminal region treated with rapid infusion of high-dose MTX and radiation: case report and review of the literature.

Surgical neurology, 2003, Volume: 60, Issue:4

Topics: Antimetabolites, Antineoplastic; Chemotherapy, Adjuvant; Cranial Irradiation; Cranial Nerve Neoplasms; Drug Administration Schedule; Humans; Infusions, Intravenous; Lymphoma; Magnetic Resonance Imaging; Male; Methotrexate; Middle Aged; Radiotherapy, Adjuvant; Spine; Treatment Outcome; Trigeminal Nerve Diseases; Trigeminal Neuralgia

2003

Other Studies

1 other study(ies) available for methotrexate and Benign Cranial Nerve Neoplasms

Article	Year
Salvage chemoimmunotherapy with rituximab, ifosfamide and etoposide (R-IE regimen) in patients with primary CNS lymphoma relapsed or refractory to high-dose methotrexate-based chemotherapy. Hematological oncology, 2013, Volume: 31, Issue:3 Topics: Aged; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Central Nervous System Neoplasms; Combined Modality Therapy; Cranial Irradiation; Cranial Nerve Neoplasms; Drug Administration Schedule; Drug Evaluation; Drug Resistance, Neoplasm; Etoposide; Eye Neoplasms; Female; Follow-Up Studies; Hematopoietic Stem Cell Transplantation; Humans; Ifosfamide; Kaplan-Meier Estimate; Lymphoma, Large B-Cell, Diffuse; Male; Methotrexate; Middle Aged; Peripheral Blood Stem Cell Transplantation; Recurrence; Remission Induction; Retrospective Studies; Rituximab; Salvage Therapy; Survival Analysis; Transplantation, Autologous; Treatment Outcome	2013

Article

Year

Salvage chemoimmunotherapy with rituximab, ifosfamide and etoposide (R-IE regimen) in patients with primary CNS lymphoma relapsed or refractory to high-dose methotrexate-based chemotherapy.

Hematological oncology, 2013, Volume: 31, Issue:3

Topics: Aged; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Central Nervous System Neoplasms; Combined Modality Therapy; Cranial Irradiation; Cranial Nerve Neoplasms; Drug Administration Schedule; Drug Evaluation; Drug Resistance, Neoplasm; Etoposide; Eye Neoplasms; Female; Follow-Up Studies; Hematopoietic Stem Cell Transplantation; Humans; Ifosfamide; Kaplan-Meier Estimate; Lymphoma, Large B-Cell, Diffuse; Male; Methotrexate; Middle Aged; Peripheral Blood Stem Cell Transplantation; Recurrence; Remission Induction; Retrospective Studies; Rituximab; Salvage Therapy; Survival Analysis; Transplantation, Autologous; Treatment Outcome

2013